Experimental Relative-Amount Explorer

Boldenone Cypionate: compare editable assumptions, not human blood levels.

Illustrative assumptions. The round starting values and example input schedule are arbitrary mathematical illustrations, not measurements, human PK estimates, or a recommended regimen for boldenone cypionate. Change them to explore sensitivity. Output uses arbitrary relative units, with no conversion to a human blood concentration.

Read the compound evidence and limitations

Assumed relative profiles

One unit is one arbitrary reference input amount. Both scenarios use the same scale; neither curve is divided by its own peak.

Vertical: relative unitsHorizontal: model days

A · highest sampled relative level: 1.614 relative units
B · highest sampled relative level: 2.856 relative units

The lines are separate what-if scenarios, not a confidence interval or a range of likely human outcomes. Sampling can miss brief peaks; a shorter view horizon reveals more detail.

Sampled relative values

Model days and sampled relative amounts; not blood concentration.
Model day	A (relative units)	B (relative units)
0	0	0
8.4	1.078	1.304
16.38	1.387	1.904
24.46	1.446	2.225
32.55	1.39	2.37
40.63	1.291	2.412
48.83	1.167	2.381
57.02	1.046	2.314
65.83	0.4388	1.498
74.97	0.1776	0.9529
84	0.07263	0.6094

Scenario A — solid line

A: assumed absorption half-life (days)

A: assumed elimination half-life (days)

Scenario B — dashed line Compare alternative assumptions

B: assumed absorption half-life (days)

B: assumed elimination half-life (days)

The initial B example doubles A's default elimination half-life. It is not an evidence-based upper bound.

Shared hypothetical input pattern

Relative input per event (arbitrary units)

Input interval (model days)

Number of model inputs

View horizon (model days)

Use one input to inspect a single response. These are mathematical settings, not a dosing schedule. Field limits keep this browser example manageable; they are not physiological ranges.

Assumptions, equations and background sources

Experimental relative-amount explorer · boldenone-cypionate-relative-assumptions, version 1.

The model transfers a relative input from a hypothetical depot into a central pool, then removes it by first-order elimination. The displayed amount uses the original input-unit scale. No distribution volume, bioavailability, molecular weight, fitted peak or testosterone calibration is used.

dD/dt = −ka × D; dX/dt = ka × D − ke × X

Absorption and elimination half-lives set ka and ke. The slow terminal tail can be absorption-controlled; an assumed elimination half-life is not necessarily the terminal half-life of the resulting curve.

No formulation-matched human plasma PK calibration was retrieved for boldenone cypionate in the source review.
One relative input unit has the same scale in every scenario. The curve is not independently normalized to its own peak.
The model assumes complete first-order transfer from a hypothetical depot followed by first-order elimination, with zero initial amounts. This is a mathematical convention, not a bioavailability claim.
Changing assumed half-lives changes the curve; the displayed alternatives are selected scenarios, not probability or confidence intervals.
Relative amounts cannot be converted to measured blood concentrations, compared with another compound's ng/dL curve or used to infer a safe dose, dosing interval, testing window or clearance date.

Background sources do not validate the selected assumptions.

NMI Australia S032: boldenone cypionate identity
Chemical identity of an analytical reference material. It does not support the illustrative kinetic assumptions.
Schänzer and Donike, 1992: oral boldenone metabolism in humans
Different route and urinary-metabolite endpoints; not a calibration of injectable cypionate plasma kinetics.